You are here

Endovascular treatment has emerged as the best thing since intravenous tissue plasminogen activator (IV t-PA) for acute ischemic stroke after five recent studies showed positive outcomes. Stent retrievers starred in the trials, with imaging playing a critical supporting role. But in clinical practice, which neuroimaging method best identifies likely beneficiaries is up for debate.

The fab five 

It all started with MR CLEAN. MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) found that acute ischemic stroke patients who had proximal intracranial occlusions and received endovascular therapy along with standard care were more likely to achieve functional independence by three months than counterparts...

 - Mary Tierney
Every year, more than 795,000 Americans suffer a stroke—with 665,000 people surviving the episode. The annual cost of stroke in the U.S. tops $33.6 billion (Circulation. 2015 ;e29-322.) and one out...
 - Mobile health
Tools that help patients adhere to doctor’s recommendations improve patient outcomes—it’s simple math with a host of benefits.
 - sharing data
Prompt response to cardiac arrest is critical; seconds lost reduce the chances for patient recovery. While other rescue procedures like CPR do help and buy rescuers time, when a shock is needed, it’s...
Special Section
 - Gary Idelchik, Saratoaga Hospital
Growth seeded the need for a dedicated PCI program at Saratoga Hospital that went live in January along with a complete technology overhaul: cath lab, hemodynamic monitoring, echocardiography and a...
Special Section
Episode 2: The Programmatic Approach to Teaching, Tactics & Techniques
The University of Washington Medical Center in Seattle, already a major national referral center, has recently undergone a significant culture shift. The change began when Robb MacLellan, MD, joined...
 - Robotics
Once just a feature of science fiction, robotics is now an integral part of the current healthcare landscape. With the advent of robotic-assisted percutaneous coronary intervention (PCI),...
 - Emergency physicians
The stars appear to be aligned for drugs that reverse the effect of novel oral anticoagulants (NOACs). Regulators in the U.S. have moved them forward, anxious to provide emergency physicians an...
 - Steven D. Pearson, MD
As the healthcare industry shifts towards a more value-based system, payers, physicians, patients and pharmaceutical companies are paying more attention to the costs and benefits of new treatments....